Our aim in this study was BV:7.69±4.28 ml/100g, BF:48.87±25.54 ml/100g/min, TTP:27.94±7.32 sec., MTT:9.56±3.47 sec. and BV:11.83±5.34 ml/100g, BF:78.75±39.41 ml/100g/min, TTP:29.72±6.05 sec., MTT:11.44±4.93 
Introduction
The use of non-invasive functional imaging methods in the detection, staging and follow-up of lung cancer has gradually become routine in clinical applications [1] . Perfusion CT is one of these methods and is a promising technique that allows functional evaluation of tissue vascularity [2] . Perfusion CT has a wide spectrum of clinical and research applications and is also being used increasingly more commonly in oncology. Its clinical applications in oncology include lesion characterization for the differentiation of benign and malignant lesions, screening for occult malignancy, prognosis prediction based on tumor vascularity, and the evaluation of the therapeutic effectiveness of many treatment methods [3, 4] .
Lunc cancer is the most common causes of cancer deaths [5, 6] . The differentiation of a centrally located tumoral mass from collapsed lung segments is especially important as current radiotherapy aims to target the tumoral tissue better, thus decreasing the dose of unnecessary radiation that normal tissues are exposed to [7] . Current radiotherapy applications use computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) for this purpose. One of the important issues in radiotherapy is differentiation of the tumor tissue from the distal consolidation areas. This differentiation is not always possible with conventional methods.
Our aim in this study was to differentiate the central mass from postobstructive atelectasis consolidation in centrally-located lung cancers with atelectasis consolidation using first-pass computed tomography perfusion parameters. Such differentiation will enable the exposure of the mass to the planned dose of radiation while the consolidation area is protected. 
Material and Method

Cases
Imaging and Analysis
A 64-detector multislice computed tomography device (Aquilion 64 Model TSX-101A;
Toshiba Medical Systems, Corporations Tochigi Japan), was used to first obtain scout and standard non-contrast images for every patient, followed by dynamic imaging and the determination of the slice position that included the mass and consolidation areas. Once the slice position was defined, an automatic syringe (Missouri, Ulrich Medikal, 31 The Netherlands) was used to inject 81.65 g iomeprol (İomeron 400, Braccos.p.a. Milano, Italy)
with an equivalent of 40 g iodine in 100 ml from the right antecubital vein at a flow rate of 5 mL/s intravenously to obtain multislice CT perfusion images. The patients were asked to hold their breath or breathe slowly during the procedure. The acquisition duration varied between 40 and 60 seconds. Deconvolution analysis was used to place a ROI on the ascending aorta as the input artery in every case and color perfusion maps were prepared. The descending aorta was selected as the input artery when the ascending aorta was not within the section. Contrast dynamic CT images of the patient were used to place ROI in 3 different localizations while avoiding the periphery of the central mass as much as possible. We also placed ROI at 3 different localizations in the periphery of the distal atelectasis area. The acquired images were transferred to a workstation for analysis and then evaluated with the Vitrea perfusion software. ROI were placed at 3 different localizations in the mass and distal atelectasis areas using the color perfusion maps. The values of the BV, BF, TTP and MTT parameters were recorded.
Statistical Analysis
The SPSS for Windows version 13.0 statistical software was used for the statistical analysis of our study. Quantitative data were provided as mean (x) ± standard deviation (SD). Our qualitative data were tested with the Shapiro-Wilks normality test. We used the unpaired t-test The cases were grouped according to their histopathology diagnoses. The tumors were grouped as small cell (SCLC) and non-small cell lung cancer (NSCLC) according to their cytology/histopathology diagnoses. There were 7 SCLC and 13 NSCLC cases.
Comparison of the mean TTP (27.94 ± 7.32 sec., 29.72 ± 6.05 sec. respectively) and MTT 
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Discussion
Lung cancer is the most common cause of cancer deaths worldwide [5] . Lung cancers can be classified as central and peripheral according to their anatomical localization. Centrallylocated tumors usually cause volume loss at the distal part of the bronchus or bronchiole that they obstruct [8] . The postobstructive consolidation or pneumonia can lead to a volume loss pattern that is segmental or lobar or includes the whole lung. It can be difficult to differentiate tumor tissue from peripheral consolidation areas due to the distal atelectasis and secretion retention caused by central tumor obstruction and the secondary pneumonia. Volume loss can be better evaluated with CT in many cases when the area of volume loss has necrotic areas within the large exophytic component of the central lesion [9, 10] . The proximal sections of the segmental bronchi and the lobar bronchi can be shown with very high quality in normal individuals. CT is a reliable modality with an acceptable false positive value in defining an obstructive tumor as the cause of atelectasis [10] .
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There are some studies in the literature aiming to differentiate between a central mass and the accompanying atelectasis tissue. A study on MR and CT imaging in the differentiation of proximal bronchogenic carcinoma from postobstructive lobar collapse has compared the definition and mass-collapsed segment differentiation using CT attenuation levels and MR signal changes based on the central tumor contour abnormalities. No difference was found between the attenuation levels of distal lobar collapse and the proximal tumor in pre-contrast images. Contrast dynamic CT imaging revealed that the collapsed segment showed more contrast enhancement than the tumor in 8 of the 19 patients and these two tissues had different attenuation levels. The same study was also able to differentiate between tumor and collapsed segment by usıng the MRI signal intensity differences [12] . Another study with the rapid CT acquisition technique has reported that there was marked contrast enhance of the collapsed segment between 40 sec and 2 min while the proximal tumor showed slow and minimal enhancement when a bolus contrast injection was performed [13] . The role of conventional MRI in differentiating the central tumor from postobstructive atelectasis is still controversial [12] . There are studies claiming that the in vivo T1 and T2 signal intensity of malignant tumors significantly overlaps the values of benign processes in the lung parenchyma [14, 15] . suggested that DAG can be used to differentiate lung cancer from collapsed lung tissue [16] .
Susceptibility and motion artifacts were emphasized as the main limiting factors of DAG in both studies [7, 16] .
A retrospective study has reported that it was possible to limit the radiotherapy area with the [19, 20, 21] .
Taking into account that functional changes appear before morphological changes during treatment, methods such as perfusion CT enable earlier evaluation of the treatment's effectiveness compared to conventional methods [20] . and PE (peak enhancement) parameters between SCLC and NSCLC cases [1] . We also did There were also some factors with a negative influence on CT perfusion in our study.
Perfusion values can be measured incorrectly in tumor areas close to large central vessels due to a beam hardening artifact. These artifacts can be controlled by using higher tube voltages.
This approach requires careful evaluation of the patient's radiation exposure.
We only evaluated the early stage pass of the contrast matter in this study. A longer protocol will enable evaluation not only of tissue perfusion but also of capillary permeability, blood flow and tumor blood volume. However, such an approach will also prolong the procedure and create a disadvantage regarding routine use in the clinic.
In conclusion, we believe that it is possible to differentiate central lung cancers from distal postobstructive atelectasis using first-pass perfusion CT parameters. This differentiation will help ensure a narrower safety range and decrease radiation toxicity in the normal tissue surrounding the tumor in patients about to receive radiotherapy during clinical procedures.
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